NCT01835561View on ClinicalTrials.gov

Study to Evaluate Pharmacokinetics of Pomalidomide in Hepatically Impaired Males

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

March 1, 2013

Primary Completion Date

August 16, 2014

Study Completion Date

August 21, 2014

Conditions

Clinical Pharmacology, Healthy Volunteer Study

Interventions

DRUG

Pomalidomide

Single oral dose of 4-mg capsule

DRUG

Pomalidomide

4-mg capsule

Trial Locations (2)

32809

Orlando Clinical Research Center, Orlando

55404

DaVita Clinical Research, Minneapolis

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY